Olink Proteomics
Olink's mission is to accelerate proteomics together with the scientific community, to understand real-time biology and gain actionable insights into human health and disease. We believe this will drive the development of better, more targeted therapies and help revolutionize future healthcare through the implementation of precision medicine. Learn more about us below!
Website
-
DEC 05, 2024 | 8:00 AM
Tuberculosis (TB) remains a disease of global significance, causing 1.3 million deaths and 10.6 million cases of active disease worldwide each year. The World Health Organization (WHO) has i... -
DEC 11, 2024 | 8:00 AM
Precision Diagnosis of Ovarian Cancer – Identification of Protein Biomarkers that Separate Benign from Malignant Tumors Ovarian cancer has the highest mortality among gynecological can...
-
OCT 02, 2024 | 11:00 AM
Inflammatory skin disorders comprise a diverse set of conditions exhibiting unique characteristics. Our objective was to systematically compare the affected and unaffected skin of individual...
-
JUN 26, 2024 | 12:00 PM
Mycosis fungoides (MF), the most common type of cutaneous T-cell lymphoma, is characterized by malignant T-cell skin infiltration leading to inflammation and skin barrier defects. To effecti...
-
JUN 11, 2024 | 8:00 AM
Cancer genome alterations that cause cancer cells to grow also confer vulnerabilities, which normal cells lack. The challenge is that, for the majority of cancers, we do not understand the r...
-
MAY 30, 2024 | 9:00 AM
Long COVID, now recognized as Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), represents a significant and growing concern in public health and medical communities. As the COVID-19 pande...
-
APR 24, 2024 | 6:00 AM
Over the past few decades, protein analysis and proteomics have emerged as crucial tools in disease risk assessment, providing a more holistic understanding of susceptibility to diseases and...
-
MAR 12, 2024 | 10:00 AM
Inflammation is associated with cognitive decline and the pathogenesis of Alzheimer's disease, although exact pathways remain elusive. To further explore the role of inflammation, we uti...
-
FEB 21, 2023 | 8:00 AMC.E. CREDITS
Date: February 21, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Cancer is a highly heterogeneous disease in need of accurate and non-invasive diagnostic tools. Here, we describe a no...
-
JAN 25, 2023 | 8:00 AM
Date: January 25, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Allogeneic hematopoietic cell transplantation (HCT) is curative for hematological diseases; however, is also associated...
